Understanding Semaglutide Semaglutide, originally developed as a medication for managing type 2 diabetes, belongs to a class of drugs known as GLP-1 receptor agonists
Malonyl-CoA inhibits carnitine palmitoyl-transferase (CPT I), which transports fatty acyl-CoA into mitochondria where it is oxidised
The problem is that the stomach doesn't always tolerate this well, especially at first
Our telehealth model gives you access to licensed providers and evidence-based treatment without leaving home whether you are in Newark, Jersey City, Hoboken, or anywhere else across the state
From there, we create a personalized plan that may include medication, nutrition adjustments, and regular follow-ups
By addressing both conditions, GLP1 therapy obesity treatments provide a more holistic strategy for chronic disease care